Clarivate Analytics
Novo Nordisk Foundation, Wellcome and Gates Foundation collaborate to accelerate global health equity
The collaboration will support solutions to address the health impacts of climate change, infectious diseases and AMR
Clinigen launches ‘What is Possible?’ campaign on Rare Disease Day to accelerate access to medicines
There are over 7,000 rare diseases impacting more than 300 million people globally
Global donors pledge over $777m to fight neglected tropical diseases at COP28 summit
The $500m Reaching the Last Mile Fund will reach an additional 32 countries
Bill & Melinda Gates Foundation commit $1.2bn as part of efforts to end polio worldwide
The pledge will aid the implementation of the GPEI’s Polio Eradication Strategy 2022-2026
Manus Bio awarded $2m by Bill & Melinda Gates Foundation to combat malaria
The additional funding will accelerate the development of a production route for artemisinin, a key therapeutic for treating malaria
Pandemic Antiviral Discovery initiative created by the Novo Nordisk Foundation, Open Philanthropy and the Gates Foundation
The initiative, backed with funding of up to $90m, will aid in the discovery and development of antiviral drug candidates
EU cross-border healthcare
The clock is ticking to improve access to gene and cell therapies for rare diseases
Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy
Project will aim to discover and develop a gene therapy for sickle cell disease
Gates Foundation, Wellcome launch fast-track COVID-19 therapy fund
Partners commit $125m to seed-fund for potential treatments
Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant
Grant will help accelerate medicine registration in low/middle-income countries
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook
NICE International relaunches, will offer advisory services
Meets growing demand from global health and social care organisations